HOME > News Releases

News Releases

2014.12.11
R&D
PDF/171KB
Investigational Drug Dasotraline Significantly Improved Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in a Placebo-Controlled Study in Adults
2014.11.18
Products
PDF/219KB
Sumitomo Dainippon Pharma obtains Approval in Japan for Partial Change of the Approved Indication to “Type 2 Diabetes” for SUREPOST, a Rapid-acting Insulin Secretagogue
2014.11.04
Corporate
PDF/126KB
Sumitomo Dainippon Pharma Announces Organizational Realignment, and Changes in Executive Officers and Other Key Positions
2014.10.30
Finances
PDF/306KB
Supplementary Financial Data for the Second Quarter of the Year Ending March 31, 2015
2014.10.30
Finances
PDF/287KB
Summary of Consolidated Financial Results for the Second Quarter of the Year Ending March 31, 2015 [Japanese GAAP] (Unaudited)
2014.10.30
Corporate
PDF/168KB
Sumitomo Dainippon Pharma Announces Transfer of a Fixed Asset
More News Releases

Page Top